Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
Moderna is seeking FDA approval for its new flu shot which uses MRNA technology.
Federal health officials say thousands of updated booster shots are already being shipped around the country.
COVID-19 vaccines for young children are on the way to Maryland days after the U.S. Centers for Disease Control and Prevention decided the shots should be made available to children under the age of five.
The first COVID-19 vaccines for children under the age of five will soon be administered in Maryland and across the country.
Shots can't be given until the US Centers for Disease Control and Prevention's vaccine advisers have voted on whether to recommend them -- a vote is scheduled for Saturday -- and CDC Director Dr. Rochelle Walensky has signed off on that recommendation.
The US could be vaccinating infants, toddlers and preschoolers against Covid-19 within days.
A government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
COVID-19 infections in people under the age of 19 are on the rise, according to data recorded by the Maryland State Department of Health.
Moderna hopes to get the green light from the Food and Drug Administration "in the coming weeks" to give the youngest population a low-dose COVID-19 vaccine.
In the United States, health officials emphasized late last year that fourth doses were not yet needed and said it was too premature to be discussing a potential fourth dose of coronavirus vaccine for most people.
U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency authorization over a year ago.
Hospitalizations and the COVID-19 positivity rate are all trending in a positive direction even as January wraps up and is set to be the deadliest month in Maryland since the onset of the coronavirus pandemic.
The Food and Drug Administration has amended the emergency use authorization for Moderna booster shots.
Governor Larry Hogan announced that Maryland has surpassed the milestone of 10 million COVID-19 vaccinations administered.
The new recommendation: "mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 years of age and over."
All eyes are on the omicron variant. While it isn't the dominant variant yet, experts say we could be heading in that direction.
There's still a lot that we don't know about the omicron variant.
All Marylanders age 18 and older are now eligible to receive a COVID-19 booster shot, Gov. Larry Hogan said Friday.
Governor Larry Hogan announced that 99 percent of Maryland seniors have now received at least one dose of the COVID-19 vaccine, according to CDC data.
Data from a real-world study assessing Johnson & Johnson's Covid-19 vaccine finds it is 73.6% effective, according to research published Tuesday in the journal JAMA Network Open.
Maryland reported 731 new COVID-19 cases and 13 new deaths, according to state health department data released Wednesday morning.
With COVID-19 boosters now available statewide, Maryland officials on Monday launched a new web portal to help residents determine if they are one of the nearly 1.4 million people in the state eligible for another shot.
Eric Robison will never run out of words to describe his wife.
